US OptionsDetailed Quotes
VKTX241129P64000
- 10.46
- -0.59-5.34%
15min DelayClose Nov 27 16:00 ET
11.05High10.46Low
11.05Open11.05Pre Close2 Volume31 Open Interest64.00Strike Price2.15KTurnover236.04%IV1.78%PremiumNov 29, 2024Expiry Date9.49Intrinsic Value100Multiplier0DDays to Expiry0.97Extrinsic Value100Contract SizeAmericanOptions Type-0.9652Delta0.0164Gamma5.71Leverage Ratio-0.3405Theta-0.0007Rho-5.51Eff Leverage0.0015Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet